ProCE Banner Activity

Targeting AKT in HER2-Negative Breast Cancer: Implications for Future Clinical Practice

Slideset

Download these slides reviewing data on investigational agents targeting AKT in HER2-negative metastatic breast cancer.

Released: July 27, 2023

Share

Faculty

Joyce O'Shaughnessy

Joyce O'Shaughnessy, MD

Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Chair, Breast Disease Committee
Sarah Cannon Research Institute
Texas Oncology
Dallas, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca